Get started
Author

Johannes Clouth

Observed names: Clouth, Johannes, J Clouth, J. Clouth
Institution: Eli Lilly (Germany)
ORCID: 0000-0001-8941-6739
Observed ORCID: 0000-0001-8941-6739
OpenAlex ID: A5029021088
The quality of life and economic burden of neuropathy in diabetic patients in Germany in 2002—Results from the diabetic microvascular complications (DIMICO) study
2008 · Michael Happich, Jürgen John, et al. · Diabetes Research and Clinical Practice · 72
Diabetic retinopathy and health-related quality of life
2008 · Eldad Davidov, Lusine Breitscheidel, et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 67
Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany
2003 · Aileen R Neilson, Hilmar Burchardi, et al. · Journal of Critical Care · 64
Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation
2000 · K. Bestehorn, M. Biller, et al. · Medizinische Klinik - Intensivmedizin und Notfallmedizin · 64
Patient preferences for outcomes of depression treatment in Germany: A choice-based conjoint analysis study
2013 · Thomas M. Zimmermann, Johannes Clouth, et al. · Journal of Affective Disorders · 62
Burden of illness imposed by severe sepsis in Germany
2002 · A. Schmid, H. Burchardi, et al. · The European Journal of Health Economics · 57
Preferences of diabetes patients and physicians: A feasibility study to identify the key indicators for appraisal of health care values
2010 · Franz Porzsolt, Johannes Clouth, et al. · Health and Quality of Life Outcomes · 36
PDF
Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany
2016 · R. Hofheinz, J. Clouth, et al. · BMC Cancer · 35
PDF
A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany
2006 · Stephen M. Beard, Fiona Maciver, et al. · The European Journal of Health Economics · 22
Use of Structural Equation Modeling to Demonstrate the Differential Impact of Storage and Voiding Lower Urinary Tract Symptoms on Symptom Bother and Quality of Life during Treatment for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia
2016 · Kevin T. McVary, Andrew Peterson, et al. · The Journal of Urology · 14
Constructing an Index for the Subjective Well-being Under Neuroleptics Scale (SWN), short form: Applying structural equation modeling for testing reliability and validity of the index
2006 · Peter Schmidt, Johannes Clouth, et al. · Quality of Life Research · 14
Kosten der Frühverrentung am Beispiel der Schizophrenie
2004 · Johannes Clouth · Psychiatrische Praxis. Supplement · 11
Expenditures of the German statutory health insurance system for patients suffering from acute coronary syndrome and treated with percutaneous coronary intervention
2009 · Heiko Friedel, Anne Delges, et al. · The European Journal of Health Economics · 9
Predisposing factors for early retirement in patients with Schizophrenia in Germany
2007 · Reinhard Schnabel, Heiko Friedel, et al. · The European Journal of Health Economics · 8
Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data
2018 · Johannes Clouth, Astra M. Liepa, et al. · Health Economics Review · 7
PDF
Kosten der Harninkontinenz in Deutschland
2007 · J.-M Graf von der Schulenburg, T Mittendorf, et al. · Gesundheitsökonomie & Qualitätsmanagement · 7
Kostenanalyse der Schizophrenie-Behandlung in Deutschland - Vergleich von Olanzapin, Risperidon und Haloperidol mit Hilfe eines klinischen Entscheidungsmodells -
2001 · C. Deckert, J. Höffler, et al. · Gesundheitsökonomie & Qualitätsmanagement · 7
Theory Behind the Bridge Principles
2007 · Hans Russ, Johannes Clouth, et al. · Springer eBooks · 5
Length of hospital stay and associated costs for olanzapine vs. haloperidol in the treatment of schizophrenia relapse in Germany
2003 · U. Reitberger, A. Spannheimer, et al. · The European Journal of Health Economics · 5
Kosten der Schizophrenie
2003 · J. Clouth, A. Uber, et al. · Gesundheitsökonomie & Qualitätsmanagement · 3
Kosten der Frühverrentung am Beispiel der Schizophrenie
2002 · R. Schnabel, J. Clouth · Gesundheitsökonomie & Qualitätsmanagement · 3
Pcn3: Cost Analysis of Schizophrenia Treatment in Germany: a Comparison of Olanzapine, Risperidone, and Haloperidol Using a Clinical Decision Model
1999 · A Spannheimer, J Clouth, et al. · Value in Health · 3
PDF
Pharmacoeconomic evaluation of the treatment of schizophrenia in Germany: A comparison of olanzapine and haloperidol
1999 · A. Spainnheimer, J. Clouth · European Neuropsychopharmacology · 3
A Retrospective Observational Study of the Epidemiology of Advanced Gastric Cancer in Germany
2014 · H. Friedel, J. Clouth, et al. · Gesundheitsökonomie & Qualitätsmanagement · 2
Die angemessene Evidenz für Therapieentscheidungen: eine Diskussion des Methodenpluralismus in klinischen Studien
2013 · F. Porzsolt, J. Bausch, et al. · Gesundheitsökonomie & Qualitätsmanagement · 2
Works count: 56
Citation count: 595
H-index: 11
I10-index: 12
Year
Topic
Type